ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselAccense S.A.
Accense S.A. Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Accense S.A. develops and markets pharmaceutical products, including meclizine-based medicines sold under the Agyrax, Postafen and Navidoxine brands. Its activities also include managing product authorisations and distribution, and seeking medicines with potential for further development.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Accense S.A.

5
Commercialisation of meclozine-based specialties
Commercialisation of Postafen, Agyrax and Navidoxine under different brands, with distribution in Europe and prescription or OTC status depending on the countries.
Acquisition and porting of pharmaceutical products
Acquisition of safe, effective pharmaceutical products, transfer and porting of the AMMs to Accense, with takeover of the meclozine-based specialty.
Pharmaceutical development and use expansion
Development of products through new indications, Rx-to-OTC status change, boosting via scientific medical information and targeted commercial development.
Research and selection of pharmaceutical products
Research on mature products that are useful for public health, well tolerated and neglected by large groups, as well as on innovative products with patient benefit.
International commercialisation and local regulatory management
Commercialisation by country, interface with health authorities, regulatory management, pharmacovigilance, medical affairs and relations with health authorities.
Trust & reputation

ranQ Trust Score of Accense S.A.: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Accense S.A. has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Accense S.A. scores 86.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Accense S.A. scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Accense S.A. scores 1.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.1.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Accense S.A. reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Accense S.A. has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Accense S.A. in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Accense S.A. by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Accense S.A. to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschengraben 10
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-432.328.257
Founded
2014 · 12 years
Last commercial register change
December 18, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    EP
    Eumedica Pharmaceuticals AG
    Basel
    SP
    Sumitomo Pharma Switzerland GmbH
    Basel
    US
    Urovant Sciences GmbH
    Basel
    BM
    BeOne Medicines AG
    Basel
    NB
    Novartis Bioventures AG
    Basel
    RC
    Roche Chemical Manufacturing and Trading Company AG
    Basel
    MM
    Mundipharma MEA GmbH
    Basel
    PA
    Prosalix AG
    Basel